Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Plasma levels of lipoprotein (a) in patients with major depressive disorders.

Hamidifard S, Fakhari A, Mahboob S, Gargari BP.

Psychiatry Res. 2009 Oct 30;169(3):253-6. doi: 10.1016/j.psychres.2008.06.033. Epub 2009 Sep 10.

PMID:
19747737
2.

Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk.

Emanuele E, Carlin MV, D'Angelo A, Peros E, Barale F, Geroldi D, Politi P.

Eur Psychiatry. 2006 Mar;21(2):129-33.

PMID:
16516110
3.

Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index.

Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Rupprecht R, Bondy B, von Schacky C.

J Clin Psychiatry. 2011 Sep;72(9):1242-7. doi: 10.4088/JCP.09m05895blu. Epub 2010 Dec 14.

PMID:
21208589
4.

Lipoprotein(a) and its correlates in Japanese and U.S. population samples.

Iso H, Koike KA, Folsom AR, Shimamoto T, Sato S, Lida M, Komachi Y.

Ann Epidemiol. 1996 Jul;6(4):324-30.

PMID:
8876843
5.

Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.

Agoşton-Coldea L, Rusu LD, Zdrenghea D, Rusu ML, Pop D, Crăciun A, Poanta L, Gatfossé M, Rosenstingl S, Mocan T.

Rom J Intern Med. 2008;46(2):137-44.

PMID:
19284085
6.

Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.

Grassi-Oliveira R, Brietzke E, Pezzi JC, Lopes RP, Teixeira AL, Bauer ME.

Psychiatry Clin Neurosci. 2009 Apr;63(2):202-8. doi: 10.1111/j.1440-1819.2008.01918.x. Epub 2009 Jan 23.

7.

Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia.

Jow GM, Yang TT, Chen CL.

J Affect Disord. 2006 Jan;90(1):21-7. Epub 2005 Dec 1.

PMID:
16324751
8.

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.

Yoshimura R, Umene-Nakano W, Hoshuyama T, Ikenouchi-Sugita A, Hori H, Katsuki A, Hayashi K, Atake K, Nakamura J.

Hum Psychopharmacol. 2010 Nov;25(7-8):566-9. doi: 10.1002/hup.1155.

PMID:
21312291
9.

Alexithymia and its relationships with C-reactive protein and serum lipid levels among drug naïve adult outpatients with major depression.

De Berardis D, Serroni N, Campanella D, Carano A, Gambi F, Valchera A, Conti C, Sepede G, Scali M, Fulcheri M, Salerno RM, Ferro FM.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1982-6. doi: 10.1016/j.pnpbp.2008.09.022. Epub 2008 Oct 7.

PMID:
18940224
10.

The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder.

Gustafsson G, Lira CM, Johansson J, Wisén A, Wohlfart B, Ekman R, Westrin A.

Psychiatry Res. 2009 Oct 30;169(3):244-8. doi: 10.1016/j.psychres.2008.06.030. Epub 2009 Sep 3.

PMID:
19729204
11.

Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder.

Soygur H, Palaoglu O, Akarsu ES, Cankurtaran ES, Ozalp E, Turhan L, Ayhan IH.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1242-7. Epub 2007 May 24.

PMID:
17587477
12.

Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.

Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS.

Clin Biochem. 2008 May;41(7-8):453-8. doi: 10.1016/j.clinbiochem.2008.01.016. Epub 2008 Feb 5.

PMID:
18280807
13.

The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.

Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.

Eur Neuropsychopharmacol. 2009 Jun;19(6):409-15. doi: 10.1016/j.euroneuro.2009.02.007. Epub 2009 Mar 26.

PMID:
19327969
14.
15.

Serum lipoprotein (a) levels and Behçet's disease: is there an association?

Balik O, Gur G, Lenk N, Artuz F, Alli N.

Int J Dermatol. 2007 Aug;46(8):827-9.

PMID:
17651165
16.

Ghrelin plasma levels are not altered in major depression.

Kluge M, Schussler P, Schmid D, Uhr M, Kleyer S, Yassouridis A, Steiger A.

Neuropsychobiology. 2009;59(4):199-204. doi: 10.1159/000223731. Epub 2009 Jun 10.

PMID:
19521111
17.

Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.

Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1023-6. Epub 2007 Mar 6.

PMID:
17433517
18.

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders.

Emanuele E, Martinelli V, Carlin MV, Fugazza E, Barale F, Politi P.

Neurosci Lett. 2011 Jan 3;487(1):99-102. doi: 10.1016/j.neulet.2010.10.003. Epub 2010 Oct 16.

PMID:
20937362
19.

Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.

Souki-Rincón A, Urdaneta J, Mengual E, Torres D, Cano-Peñaloza R, García-Camacho D, Bermúdez-Pírela V, Sorell L, Cano-Ponce C, Almarza J, Israili Z, Hernández-Hernandez R, Velasco M.

Am J Ther. 2008 Jul-Aug;15(4):403-8. doi: 10.1097/MJT.0b013e31815fa7a6.

PMID:
18645346
20.

Leptin and lipid metabolism in chronic kidney failure.

Kastarinen H, Kesäniemi YA, Ukkola O.

Scand J Clin Lab Invest. 2009;69(3):401-8. doi: 10.1080/00365510802706645.

PMID:
19148833

Supplemental Content

Support Center